Author: openjargon

If I had $10,000 to invest in ASX 200 shares in FY27, I would focus on businesses with room to grow for years.

The market can move quickly, and FY27 will almost certainly bring surprises. But I think the best starting point is still quality.

With that in mind, these are three ASX 200 shares I would consider buying.

Netwealth Group Ltd (ASX: NWL)

Netwealth is one ASX 200 share I would want exposure to in FY27.

At its core, the company helps financial advisers and their clients manage wealth through a modern investment platform. But I think the more interesting point is what that platform allows advisers to do.

Advice businesses are under pressure to serve clients more efficiently, manage more paperwork, provide better reporting, and build portfolios that can be tailored to individual needs. That creates a strong reason for advisers to use technology that reduces friction. Netwealth sits inside that workflow.

The company benefits when more funds move onto its platform, but I think the long-term opportunity is about more than simply gathering assets. It is about becoming part of the operating system for wealth advice.

Australia has a large pool of retirement savings, and many investors will need help managing that money over time. If Netwealth can keep making advisers’ jobs easier, it should have a long runway.

Breville Group Ltd (ASX: BRG)

Breville is another ASX 200 share I would buy for FY27.

I see Breville as a business built around small moments that happen every day. Coffee in the morning, toast before school, dinner after work, and a weekend meal prepared properly.

That may sound simple, but those routines are exactly why the brand can be powerful. A well-designed kitchen appliance can become part of daily life, and customers who trust the brand may return when they upgrade or move into a new category.

Breville also has a global opportunity. The company is not limited to Australia, and its premium positioning can travel well if the products keep earning their place on kitchen benches.

The coffee category remains an important growth driver, but I also like the broader idea. Breville is trying to sell better tools for the home, not just appliances. That gives it a richer brand story than a standard retailer.

Overall, I think Breville’s design culture, international reach, and category focus make it one of the more interesting consumer growth shares on the ASX.

Lovisa Holdings Ltd (ASX: LOV)

Lovisa is the third ASX 200 share I would consider for FY27.

The jewellery retailer has built a business around fast product turnover, affordable pricing, and a store format that can be rolled out across many markets.

What I find interesting is the repeat nature of the purchase. Lovisa is not selling items that customers necessarily buy once every few years. Fashion jewellery can be tied to outfits, events, gifting, travel, seasons, and changing styles. That gives the business plenty of chances to bring customers back.

The model also has a useful simplicity. Small-format stores, high product density, and a sharp focus on one category can support attractive economics when execution is strong.

But the global store opportunity is the main attraction in my opinion. Lovisa has already shown that the concept can work outside Australia, and I think there is still room to expand in existing and new markets. And if management continues to execute, Lovisa could be a much larger company over the long term.

Foolish takeaway

If I were investing $10,000 in ASX 200 shares in FY27, I would want businesses that can become more valuable through execution rather than simply waiting for the economy to improve.

Netwealth, Breville, and Lovisa all have different growth engines, but each has a clear way to keep expanding if management keeps making good decisions.

That is the appeal for me. FY27 may bring volatility, but quality businesses with long runways can still reward investors who give them enough time.

The post Where I’d invest $10,000 in ASX 200 shares in FY27 appeared first on The Motley Fool Australia.

More reading

• Forget CBA: 3 ASX shares with better growth prospects
• 10 ASX 200 shares given buy ratings this week
• Top brokers name 3 ASX shares to buy now
• How much is needed in superannuation to target an $8,000 monthly passive income?
• 3 incredible ASX growth shares tipped to rise 20% to 70%

Motley Fool contributor Grace Alvino has positions in Lovisa. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Lovisa and Netwealth Group. The Motley Fool Australia has positions in and has recommended Netwealth Group. The Motley Fool Australia has recommended Lovisa. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Temple & Webster Group Ltd (ASX: TPW) has been a painful share to own over the past year.

The online furniture and homewares retailer has fallen heavily, which means investors have clearly lost confidence in the near-term outlook.

In fact, Temple & Webster shares ended last week at $5.67, which is 80% below its 52-week high of $29.06.

Despite the market falling out of love with it, I think the longer-term opportunity is still worth taking seriously.

But it is important to remember that this is a higher-risk ASX growth share. Even so, I think Temple & Webster could be worth the risk for patient investors.

A large market moving online

Furniture and homewares is a big category. People need beds, sofas, tables, chairs, rugs, lighting, storage, office furniture, outdoor settings, and décor. Those purchases can be delayed when conditions are tough, but the category does not disappear.

The long-term question is how much of that spending keeps shifting online.

I think Temple & Webster is well placed if more customers become comfortable buying larger household items digitally. Online shopping allows people to compare products, styles, colours, dimensions, reviews, and prices without walking through multiple stores.

That can be especially useful in furniture, where range matters.

A traditional store has limited floor space. Temple & Webster can offer a much broader catalogue, giving customers more choice across styles and price points.

The model has attractive potential

The appeal of Temple & Webster is not just the online furniture theme.

It is the possibility that scale can make the business more efficient over time.

As the brand grows, the company should have more data on what customers want, which products convert, where demand is strongest, and how to improve the buying experience. Better data can help with marketing, product range, pricing, and customer retention.

The business can also keep improving delivery, supplier relationships, and private label opportunities.

That does not guarantee success. Execution will be crucial. But I like businesses where the model can become stronger with scale, and Temple & Webster has that potential.

Why I’d consider buying

I think the market can become too focused on the short-term discomfort around consumer discretionary retail.

Consumer spending is under pressure at times, just like now as interest rates rise, and furniture can be a lumpy category. But investors buying today are not buying the same share price as a year ago.

They are buying a business with a lower market valuation and, in my view, a long runway if management keeps improving the customer proposition.

Temple & Webster will suit investors who can accept volatility. It is unlikely to feel like a smooth ride. But I think the online opportunity, brand position, and operating leverage potential make it one ASX growth share worth considering after its heavy fall.

Foolish takeaway

Temple & Webster is not a defensive stock. It is a growth share that requires patience and a tolerance for uncertainty.

That said, the business is operating in a large category where online penetration can still grow. If the company keeps building trust, improving range, sharpening logistics, and using data well, the current weakness could eventually look like an opportunity.

I think this is a share for investors who can look past a difficult period and focus on what the business could become over the next five to 10 years.

The post Down 80%, could this ASX growth share be dirt cheap? appeared first on The Motley Fool Australia.

More reading

• Down 65%+, why I’d buy and hold these ASX shares
• Here are the top 10 ASX 200 shares today
• Here are the top 10 ASX 200 shares today
• Why did ASX 200 retail shares outperform last week?
• Why might Pro Medicus shares soon be under pressure?

Motley Fool contributor Grace Alvino has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Temple & Webster Group. The Motley Fool Australia has recommended Temple & Webster Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Some investors spend years searching for the perfect ASX share.

They wait for the perfect entry point, the perfect broker note, the perfect chart setup, or the perfect market conditions.

The bigger opportunity may be much simpler.

For many investors, the most powerful strategy is to just buy quality ASX shares and exchange traded funds (ETFs) regularly, then give the portfolio enough time to compound.

It sounds almost too basic, but that is exactly why it can work.

The habit matters more than the headline

Markets are noisy. There will always be a reason to wait. Interest rates may look uncertain, valuations may look stretched, earnings season may be approaching, or the economy may feel too fragile.

The problem with waiting for comfort is that markets rarely offer it at the right time.

Regular investing removes some of that pressure. Instead of trying to guess the best day to buy, investors put money to work consistently across different market conditions.

That means some purchases will be made when prices are high, some when prices are low, and many when the outlook feels unclear.

Over long periods, this can help investors build a meaningful portfolio without relying on perfect timing.

Where should you invest?

Regular investing works best when the money is going into assets that can grow over time.

That could mean broad ASX ETFs such as the Vanguard Australian Shares Index ETF (ASX: VAS), which gives investors exposure to a large basket of local companies, or the iShares S&P 500 ETF (ASX: IVV), which provides access to many of the largest businesses in the United States.

It could also mean high-quality companies with long growth runways.

Goodman Group (ASX: GMG) has exposure to logistics, industrial property, and data centres, Wesfarmers Ltd (ASX: WES) owns strong retail and industrial businesses, including Bunnings and Kmart, and Xero Ltd (ASX: XRO) operates in cloud accounting and small business software.

These types of investments can still fall in value, sometimes sharply. But the long-term goal is to own assets that become more valuable as earnings, cash flow, dividends, and market positions improve.

The strategy is simple, but the discipline is hard

The mechanics are straightforward. Choose a regular amount to invest, pick a small group of quality shares or ETFs, add money consistently, reinvest dividends where appropriate, and review the portfolio occasionally rather than obsessing over every daily move.

The harder part is emotional. Investors need to keep going when markets fall, when other people appear to be making faster money, and when the portfolio feels like it is moving too slowly.

This is where a simple plan can help. A regular investment schedule reduces the temptation to keep changing strategy. A focus on quality reduces the risk of chasing weak businesses and a long time horizon gives the portfolio space to recover from inevitable setbacks.

The key takeaway

Getting rich from ASX shares does not require constant trading or finding the next market darling.

A more realistic path is built around regular investing, quality assets, dividend reinvestment, patience, and time.

It may feel slow at first. But slow can become powerful when it is repeated for long enough.

For investors who can stick with the process, this simple ASX investing strategy could quietly become one of the best wealth-building decisions they ever make.

The post The ASX investing strategy that could quietly make you rich appeared first on The Motley Fool Australia.

More reading

• Down but not out: 3 ASX tech shares ripe for a rebound
• 4 ASX ETFs to help you sleep through market crashes
• Buy, hold, sell: CSL, Steadfast, and Wesfarmers shares
• How I’d invest $250 a week in ASX shares to aim for $700,000
• New to investing? 3 ASX shares to set and forget until 2036

Motley Fool contributor James Mickleboro has positions in Goodman Group and Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goodman Group, Wesfarmers, Xero, and iShares S&P 500 ETF. The Motley Fool Australia has positions in and has recommended Xero. The Motley Fool Australia has recommended Goodman Group, Wesfarmers, and iShares S&P 500 ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

WiseTech Global Ltd (ASX: WTC) shares are being heavily sold off on Monday after media reports about its founder, Richard White.

At the time of writing, the WiseTech share price is down a massive 12.83% to $32.15.

The ASX 200 tech stock fell as low as $31.65 in early trade, which puts it back around levels last seen in 2021.

It has been a very rough run for shareholders. WiseTech shares are now down more than 50% since the start of 2026 and around 70% lower than this time last year.

So, what has sparked the latest fall?

WiseTech caught in media storm

WiseTech is back in the headlines today after media reports that the Australian Federal Police (AFP) is investigating White over alleged sex and trafficking matters.

The allegations relate to a former cleaner at WiseTech. It has been claimed that White exploited the woman’s immigration status and financial position and provided false information on a visa application.

White has reportedly declined to comment on the claims.

This is a serious development, and the timing is far from ideal. WiseTech has already spent much of the past year dealing with leadership, governance, and regulatory issues.

The company has not released a new ASX announcement on the matter at the time of writing.

Another hit after a difficult year

WiseTech is best known for its CargoWise software, which is used across the logistics and global trade industry.

Even with today’s headlines, the business itself has continued to grow. Earlier this year, WiseTech posted first-half underlying net profit of $114.5 million and reaffirmed its full-year outlook.

It also announced plans to cut about 2,000 jobs over two years as it uses more artificial intelligence (AI) across the business.

However, the share price tells a very different story today.

White remains closely tied to WiseTech. The company’s website lists him as co-founder, Executive Chair, and Chief Innovation Officer. It also notes that he was Chief Executive until October 2024, before being appointed Executive Chair in February 2025.

What should investors watch now?

The next thing to watch is whether WiseTech responds to the latest claims or gives shareholders more detail.

Investors will also want to know whether the latest headlines affect the company’s leadership or longer-term plans.

This isn’t the first time regulatory scrutiny has weighed on the stock.

In October, ABC reported that ASIC and the AFP had searched a WiseTech office as part of an investigation into alleged trading in WiseTech shares by White and 3 employees.

At the time, WiseTech said no charges had been laid and there were no allegations against the company itself.

The post WiseTech shares crash 12% as founder scandal deepens appeared first on The Motley Fool Australia.

More reading

• Down but not out: 3 ASX tech shares ripe for a rebound
• Is the only way up for WiseTech shares after a 65% fall?
• How to know when a beaten-down ASX share is worth buying
• Why WiseTech shares could rise 95% to 165%
• If the ASX 200 rallies in the back half of the year these sectors could be portfolio winners

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended WiseTech Global. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

DroneShield Ltd (ASX: DRO) shares are taking off today.

Shares in the S&P/ASX 200 Index (ASX: XJO) drone defence company closed on Friday trading for $2.74. In morning trade on Monday, shares are changing hands for $2.85 each, up 4.0%.

For some context the ASX 200 is down 0.2% at this same time amid investor concerns over the renewed closure of the Strait of Hormuz over the weekend.

Now, here’s what’s catching investor interest in DroneShield on Monday.

DroneShield shares jump on key board appointment

DroneShield shares look to be getting a lift after the company announced that it has appointed retired Rear Admiral Lee Goddard as an independent non-executive director. Goddard will step into the new leadership role on 1 July.

Goddard currently serves as a non-executive director of Austal Ltd (ASX: ASB), Southern Launch and the Commonwealth Superannuation Corporation.

He is reported to have more than 30 years of leadership experience across defence, national security, government and industry.

His service with the Royal Australian Navy culminated in the rank of Rear Admiral. DroneShield noted that this enabled Goddard to develop expertise in defence capability, strategic planning, government acquisition systems, international defence cooperation and stakeholder engagement across Australia, the United States and allied nations.

What did management say?

Commenting on the appointment which could help support DroneShield shares longer-term, chairman Hamish McLennan said: “Lee brings an exceptional combination of defence, national security, government and board experience to DroneShield.”

McLennan continued:

His appointment further strengthens the board’s capabilities and forms part of our ongoing board renewal process as DroneShield continues its rapid growth as a global leader in counter-drone and defence technology solutions.

Throughout his career he has operated at the highest levels of the Australian Defence Force and government, while more recently building a strong track record as a director in defence and relevant industry organisations.

His understanding of military capability, defence procurement and strategic stakeholder engagement will be highly valuable as DroneShield continues to expand globally and deepen its relationships with defence customers and allied governments.

Goddard added, “DroneShield has built a strong reputation as an innovative Australian defence technology company with growing international relevance.”

He concluded, “I am delighted to join the board and look forward to contributing my experience in defence, government and international security as the company pursues its next phase of growth.”

With today’s intraday gains factored in, the DroneShield share price is up 59.2% in 12 months, racing ahead of the 4.1% one-year gains posted by the ASX 200.

The post DroneShield shares lifting off on Monday amid big leadership news appeared first on The Motley Fool Australia.

More reading

• Here are the 10 most shorted ASX shares
• 8 ASX shares with 30% to 220% upside ahead: Experts
• Own DroneShield shares? Here’s some big news
• What on earth’s going on with DroneShield shares?
• Down 37%. Has the market lost interest in DroneShield shares?

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended DroneShield. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Healthcare shares are underperforming today, down 0.33%, while the benchmark S&P/ASX 200 Index (ASX: XJO) is 0.15% lower.

Healthcare led the 11 market sectors last week with a 4.84% rise compared to a 0.28% lift for the ASX 200.

The sector has been a poor performer over the past 12 months, down 39% overall amid many industry challenges.

These include US currency headwinds; three interest rate rises in Australia; cost of living pressures leading people to delay procedures; higher shipping costs; new limits on insurance payouts in some nations; higher wage costs; and regulatory uncertainty in the US.

However, things may be changing.

On 3 June, the S&P/ASX 200 Health Care Index (ASX: XHJ) touched a 9-year low of 21,947.2 points.

Since then, ASX 200 healthcare shares have lifted 12.8% while the broader ASX 200 has managed only a 0.37% gain.

This may signal that a sector rebound has begun.

Despite these green shoots, experts maintain sell ratings on several ASX 200 healthcare shares, as showcased on The Bull this week.

Let’s hear them out.

CSL Ltd (ASX: CSL)

The CSL share price is $114.30, down 1.6% today and down 52% over 12 months.

Niv Dagan from Peak Asset Management has a sell rating on the market’s largest ASX 200 healthcare share.

The expert commented: 

A sell rating is justified as this biotechnology giant has materially downgraded its fiscal year 2026 outlook while announcing about $5 billion of additional non-cash pre-tax impairments across fiscal years 2026 and 2027.

Revenue expectations have been reduced due to US immunoglobulin channel normalisation and weaker albumin prices in China.

The CSL Vifor acquisition has under-performed. Also, government healthcare cost pressures and a higher interest rate environment present ongoing challenges for the biotechnology sector, further weighing on sentiment.

Cochlear Ltd (ASX: COH)

The Cochlear share price is $117.55, down 0.5% today and down 60% over 12 months.

Dagan also has a sell rating on this ASX 200 healthcare share. 

He explained: 

In April, the hearing implants maker materially reduced its fiscal year 2026 underlying net profit guidance to between $290 million and $330 million from between $435 million from $460 million in February.

The downgrade was a response to weaker than expected demand in developed markets amid Middle East uncertainty, lower margins and foreign exchange headwinds.

Hospital capacity constraints amid softer consumer sentiment and reduced referral activity are weighing on implant volumes, while cost base restructuring is likely to impact earnings in the near term.

Monash IVF Group Ltd (ASX: MVF)

The Monash IVF share price is steady on Monday at 71 cents.

This ASX 200 healthcare share has defied sector trends to rise 12.7% over 12 months.

But it’s been a bumpy road, as the chart below shows, and Christopher Watt from Bell Potter gives the stock a sell rating.

Watt said: 

The fertility services company recently downgraded fiscal year 2026 guidance. It now expects underlying net profit after tax to range between $17 million and $18 million.

Across the Australian market, stimulated cycle volumes were down 4.7 per cent on a rolling three month basis to the end of April when compared to the prior corresponding period.

Cost-of-living pressures and declining birth rates are structural headwinds for the whole industry.

New leadership has a genuine reset opportunity, but until there’s evidence of an industry-wide recovery, I remain cautious.

The post 3 ASX healthcare shares to sell despite signs of sector rebound appeared first on The Motley Fool Australia.

More reading

• Buy, hold, sell: Life360, Woodside, CSL shares
• Why CSL, Westpac, and this big-name ASX 200 share could be sells
• Here’s where I would invest $5,000 in ASX shares
• Buy, hold, sell: CSL, Steadfast, and Wesfarmers shares
• How to know when a beaten-down ASX share is worth buying

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Cochlear. The Motley Fool Australia has recommended CSL and Cochlear. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Atlas Arteria Ltd (ASX: ALX) has just announced a 50% boost to its full-year dividend payouts as it moves to fend off a takeover bid from Diamond Infraco.

Already generous dividend increased further

The toll roads operator previously had a dividend target of 40 cents per share, but on Monday morning, it said in a statement to the ASX that this target would be increased to 60 cents per share.

The company said:

The Independent Directors now intend to target paying distributions to ALX Securityholders of at least 60.0 cents per ALX Security in the 12 months following the end of the Offer Period made up of ordinary distributions of 40.0 cents per ALX Security and additional distributions of at least 20.0 cents per ALX Security. These distributions are expected to be funded by a combination of distributions from Atlas Arteria’s portfolio cash flows, proceeds from potential asset sales and, where appropriate, utilising corporate borrowing proceeds.

The offer period refers to Diamond Infraco’s $5.10 per share takeover offer, which Atlas Arteria’s directors are recommending shareholders reject.

Atlas Arteria said the increased dividends would likely have the effect of reducing dividends further out by 2 cents per share.

The company also said it was engaging in more discussions around asset sales.

The company said:

Atlas Arteria continues to progress initiatives to unlock value from its portfolio of world-class assets. In addition to progressing the potential divestment of the Chicago Skyway, Atlas Arteria has entered into exclusive discussions with Eiffage S.A., a leading French concession and construction group, in relation to the potential sale of Atlas Arteria’s 100% stake in the Warnow Tunnel in Germany. In the event a sale to Eiffage proceeds, Atlas Arteria expects that the sale price will be consistent with the Independent Expert’s range of €100m to €115m. Warnow Tunnel is the smallest asset in Atlas Arteria’s portfolio, and the possible divestment will not have a material impact on the future strategy of the group.

Diamond Infraco recently said its $5.10 per share offer for the company was its best and final offer.

Shares are worth more, company says

Atlas Arteria said in its statement on Monday that, “the Offer continues to materially undervalue Atlas Arteria and does not reflect an appropriate control premium for ALX Securityholders”.

An independent expert’s report has concluded that the offer is neither fair nor reasonable, and that an appropriate value for Atlas Arteria would be $5.39 to $6.20 per share.

Atlas Arteria shares were changing hands for $5.10 on Monday morning. At that price, the 60-cent per share dividend equates to a dividend yield of 11.8%.

The post How does an 11.8% dividend yield sound? appeared first on The Motley Fool Australia.

More reading

• Diamond Infraco’s $5.10 offer for Atlas Arteria now unconditional
• Atlas Arteria urges shareholders to reject IFM’s $5.10 takeover bid
• Atlas Arteria: Takeover offer lifted to $5.10 per security
• Atlas Arteria takeover bid extended
• Atlas Arteria reiterates ‘reject’ on IFM bid, maintains 2026 distribution guidance

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares are down 0.2% to 8,815.3 points on Monday.

The market is jittery after Iran said it had re-closed the Strait of Hormuz over the weekend after Israel bombed Lebanon.

US and Iran officials are in Switzerland for further discussions after both parties signed an interim peace deal last week.

Meanwhile on The Bull this week, two experts give us their views and ratings on three ASX 200 shares.

Let’s check them out. 

Life360 Inc (ASX: 360)

The Life360 share price is $23.88, up 0.2% today and down 26% in the calendar year to date (YTD). 

Christopher Watt from Bell Potter Securities has a buy rating on this ASX 200 tech share. 

Watt explains: 

This information technology company provides a mobile networking safety app for families.

Active user growth is rebounding following a technical issue, while paying circle growth, which drives revenue, recently exceeded expectations.

Guidance was upgraded. Once focus returns to paying circles, I expect a re-rating to follow.

The upcoming August result is a catalyst.

The company has been enjoying strong price momentum, with the shares rising from $17.91 on May 20 to trade at $22.54 on June 18.

Woodside Energy Group Ltd (ASX: WDS)

The Woodside share price is $29.18, up 0.5% today and up 23% YTD. 

Niv Dagan from Peak Asset Management has a hold rating on this ASX 200 energy share. 

Dagan said: 

Operationally, the energy giant continues to execute strongly. It achieved an 11 per cent increase in the average realised price of a barrel of oil equivalent in the first quarter of 2026 when compared to the fourth quarter of financial year 2025.

However, quarterly production fell by 8 per cent due to seasonal weather events. The Scarborough energy project was 96 per cent complete and remains on track for first LNG cargo in the fourth quarter of 2026.

Other major projects remain on budget and on schedule.

CSL Ltd (ASX: CSL)

CSL shares are $113.09, down 2.8% today and down 34% YTD. 

Dagan has a sell rating on this ASX 200 healthcare share.

The analyst said CSL shares deserve a sell rating after the company downgraded its outlook for FY26.

He commented: 

A sell rating is justified as this biotechnology giant has materially downgraded its fiscal year 2026 outlook while announcing about $5 billion of additional non-cash pre-tax impairments across fiscal years 2026 and 2027.

Revenue expectations have been reduced due to US immunoglobulin channel normalisation and weaker albumin prices in China.

The CSL Vifor acquisition has under-performed. Also, government healthcare cost pressures and a higher interest rate environment present ongoing challenges for the biotechnology sector, further weighing on sentiment.

The post Buy, hold, sell: Life360, Woodside, CSL shares appeared first on The Motley Fool Australia.

More reading

• 3 ASX healthcare shares to sell despite signs of sector rebound
• Why CSL, Westpac, and this big-name ASX 200 share could be sells
• Experts name 3 ASX 200 shares to buy
• Down but not out: 3 ASX tech shares ripe for a rebound
• 5 things to watch on the ASX 200 on Monday

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Life360. The Motley Fool Australia has positions in and has recommended Life360. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

ASX All Ords gold stock Barton Gold Holdings Ltd (ASX: BGD) has had a tough time of it in 2026.

In early morning trade on Monday, Barton Gold shares are down 0.6%, trading for 79 cents apiece. This sees the share price down 39.7% year to date.

For some context, the All Ordinaries Index (ASX: XAO) is down 0.1% today and up 0.1% this year.

The ASX All Ords gold stock has faced a few tailwinds this year.

Among those was the somewhat dilutive capital raising in June. The miner has also faced a declining gold price, with the yellow metal down 24% since its 28 January peak.

And Barton Gold is still primarily an explorer waiting to transition to a producer to take advantage of the still historically high gold price. (Despite the sizeable retrace since late January, the current gold price of US$4,141 per ounce remains up 23% since this time last year.)

Speaking of becoming a producer, today the miner announced that it’s taking a big step towards making that transition.

ASX All Ords gold stock appoints GR Engineering

In what could be a welcome longer-term development, Barton Gold reported that it has started a Pre-Feasibility Study (PFS) at its Tunkillia Gold Project, located in South Australia. ,

The ASX All Ords gold stock has appointed GR Engineering Services Ltd (ASX: GNG) to lead the PFS.

In May Barton Gold’s Optimised Scoping Study (OSS) revealed that Tunkillia has the potential to produce around 120,000 ounces of gold and 260,000 ounces of silver annually.

At current gold and silver prices, the miner said that Tunkillia is modelled to produce approximately $1.75 billion in operating profit during the first 27 months of production.

The miner’s 60,000 metre reverse circulation (RC) and 3,000m diamond (DD) drilling campaigns are scheduled for completion in September 2026 to support JORC Resource upgrades and the PFS analyses.

What did Barton Gold management say?

Commenting on the commencement of the PFS that could support the ASX All Ords gold stock over the longer term, Barton managing director Alexander Scanlon said:

Tunkillia’s OSS demonstrated the financial and capital leverage available to large-scale bulk processing operations, with robust economics driven by higher-grade ‘Starter Pits’ modelled to generate $1.75 billion operating profit during the first 2.5 years at current gold and silver prices and thus paying back development costs four times over during this time.

On the appointment of GR Engineering, Scanlon added, “We are pleased to be working again with GR Engineering, who delivered Tunkillia’s 2025 Optimised Scoping Study to a very high standard.”

Barton expects the PFS to be completed during the first quarter of calendar year 2027.

The post Guess which beaten-down ASX All Ords gold stock is pushing towards production appeared first on The Motley Fool Australia.

More reading

• Up 58% in a year, ASX All Ords gold stock announces major WA milestones
• Which ASX All Ords gold stock is newly cashed up and ready for growth?
• ASX All Ords gold stock lifting off today on higher-grade gold intercepts
• Record high: This ASX stock is surging on new project wins
• Why Fisher & Paykel Healthcare, GR Engineering, Kogan, and Wesfarmers shares are pushing higher

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Accent Group Ltd (ASX: AX1) shares are in focus on Monday after the footwear and apparel retailer responded to Frasers Group’s takeover offer.

At the time of writing, the Accent share price is down 0.68% at 73.5 cents.

That means the stock is still up almost 40% over the past month, although it remains around 20% lower since the start of 2026.

So, what did Accent have to say?

Accent tells shareholders to reject the offer

In a statement to the ASX, Accent said its Independent Board Committee has unanimously recommended that shareholders reject Frasers’ unsolicited on-market takeover offer.

Frasers is offering 65 cents cash per share for the Accent shares it doesn’t already own.

However, Accent has told shareholders to take no action and not sell into the offer.

The company warned that shareholders who accept the offer would miss out on any future upside from its strategy. They could also miss out on any higher offer from Frasers or another proposal that may come along.

Accent said it plans to set out the full reasons for its recommendation in its target’s statement.

Why did the board say no?

There were a few reasons for knocking back the offer.

Firstly, Accent said the 65 cents offer does not include a premium. It is equal to the last closing price before the offer was announced and below Friday’s closing price of 74 cents.

It also described the offer as materially inadequate. In the board’s view, it does not properly reflect the company’s strategic position, medium-term growth plans, or the benefits expected from its cost and trading program.

Furthermore, Accent took a bit of an issue with the timing.

It said the offer has landed during a weak period in the discretionary retail cycle, after its share price had already fallen over the past 12 months.

The board also pointed out that Frasers has previously paid much higher prices for Accent shares. This included $1.718 per share under a subscription agreement in May 2025 and an average price above 92 cents for on-market purchases in February.

Why Sports Direct is caught in the middle

There appears to be a lot of the disagreement on Sports Direct.

Accent pushed back on the idea that Frasers should gain more control without paying a proper control premium.

According to the company, Frasers has made clear that one of its goals is to increase its holding and gain influence over the board.

Frasers is also looking for more involvement in the Sports Direct ANZ business, which Accent described as a key strategic asset and a core part of its growth plans.

The board disagrees with a number of claims made by Frasers about Accent’s board and management, including around the Sports Direct roll-out and communication between the two companies.

What happens from here?

Shareholders will now be waiting for Accent’s target’s statement, which should provide more detail on the board’s view.

And while the takeover bid has helped support the share price, Accent is clearly arguing that 65 cents is not enough.

Now the next question is whether Frasers comes back with a better offer or digs its heels in for a longer takeover fight.

The post This ASX retail stock just rejected a takeover bid. Is a bigger offer coming? appeared first on The Motley Fool Australia.

More reading

• 6 ASX shares upgraded by analysts this week
• Is the ASX takeover target a buy?
• 5 things to watch on the ASX 200 on Thursday
• Buy, hold, sell: Accent, Karoon Energy, and Transurban shares
• Why Accent, IperionX, Northern Star, and Sigma Healthcare shares are racing higher on Monday

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Accent Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.